You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Indications for use
Please refer to the Symplicity Spyral™ renal denervation system instructions for use in your country for the indications for use.
Rare < 1% (less than 1 in 100 chance), temporary and not severe unless otherwise indicated
Very Rare < 0.1% (less than 1 in 1000 chance)
There are additional risks that could possibly be associated with the denervation procedure/response to treatment. These complications have not yet been quantified. These potential risks may include:
There are additional risks that could possibly be associated with the tests and procedures performed for the clinical study.
The device has not been evaluated in patients who are pregnant, nursing, or plan to become pregnant.
For distribution only in markets where the Symplicity Spyral™ multi-electrode renal denervation catheter and Symplicity G3™ renal denervation RF generator have been approved. Not for distribution in the USA, Japan or France.
Sign up for updates about the Symplicity blood pressure procedure.Subscribe
Request more information about the Symplicity blood pressure procedure.Request info
Connect with a Medtronic representative.Connect with rep